Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Raymond James Maintains Outperform on HCA Healthcare, Raises Price Target to $330

Author: Benzinga Newsdesk | January 31, 2024 08:57am
Raymond James analyst John Ransom maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target from $300 to $330.

Posted In: HCA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist